We are live on ! Find out more
CELG.RT

Bristol-Myers Squibb Rights
CELG.RT

18 hedge funds and large institutions have $156K invested in Bristol-Myers Squibb Rights in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more capital invested

Capital invested by funds: $92.4K → $156K (+$63.9K)

6% more funds holding

Funds holding: 17 → 18 (+1)

0% more ownership

Funds ownership: 0.02% → 0.03% (+0%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FCM
FourWorld Capital Management
New York
+$11.3K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$706

Top Sellers

Rank Fund Capital Flow
1
DC
Davenport & Co
Virginia
-$317
2
Citadel Advisors
Citadel Advisors
Florida
-$151
3
UBS Group
UBS Group
Switzerland
-$26
4
Bank of America
Bank of America
North Carolina
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
1
FourWorld Capital Management
New York
$69K +$11.3K +100,000 New
MS
2
Maven Securities
Jersey
$46.8K – – –
TCA
3
Transcend Capital Advisors
New Jersey
$13K – – –
DC
4
Davenport & Co
Virginia
$10K -$317 -2,800 -3%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$8.09K +$706 +6,238 +9%
Citadel Advisors
6
Citadel Advisors
Florida
$4.51K -$151 -1,333 -3%
Fifth Third Bancorp
7
Fifth Third Bancorp
Ohio
$2.2K – – –
PAG
8
Private Advisor Group
New Jersey
$1.27K – – –
TPA
9
Trivium Point Advisory
Connecticut
$1.1K – – –
Bank of America
10
Bank of America
North Carolina
$183 -$1 -5 -0.3%
CCP
11
Carmel Capital Partners
California
$66 – – –
UBS Group
12
UBS Group
Switzerland
$45 -$26 -232 -36%
Northwestern Mutual Wealth Management
13
Northwestern Mutual Wealth Management
Wisconsin
$27 – – –
Morgan Stanley
14
Morgan Stanley
New York
$18 – – –
OC
15
Oakworth Capital
Alabama
$14 – – –
Wells Fargo
16
Wells Fargo
California
$3 – +1 +4%
WP
17
WealthPLAN Partners
Nebraska
$1 – – –

CELG.RT Hedge Fund Activity: Q2 2023 in Review

18 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q2 2023, worth a combined $156K — up 69% from $92.4K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CELG.RT positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 4 trimmed.

The largest buyer was FourWorld Capital Management, opening a new position worth an estimated $11.3K. The largest seller was Davenport & Co, cutting an estimated $317.

  • 18 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q2 2023, up from 17 in Q1 2023.
  • Funds reported $156K of Bristol-Myers Squibb Rights stock for Q2 2023, up 69% quarter-over-quarter.
  • 1 fund opened new Bristol-Myers Squibb Rights positions in Q2 2023 and 0 closed out, a net change of +1 holder.
  • The largest Bristol-Myers Squibb Rights buyer in Q2 2023 was FourWorld Capital Management, an estimated $11.3K added.
  • The largest Bristol-Myers Squibb Rights seller in Q2 2023 was Davenport & Co, an estimated $317 sold.

Based on aggregated 13F filings for Q2 2023.